Variability in Cinacalcet Prescription across US Hemodialysis Facilities.

ABSTRACT:

Background and objectives

Calcimimetic drugs used to treat secondary hyperparathyroidism are being considered for inclusion in the Medicare ESRD Prospective Payment System bundle after an evaluation period. Understanding of utilization patterns of calcimimetics across dialysis facilities may help align financial incentives with clinical objectives. Our study's purpose was to describe the distribution of cinacalcet prescription across United States hemodialysis facilities and to explore factors that may influence cinacalcet utilization.

Design, setting, participants, & measurements

We used monthly cross-sectional data from the Dialysis Outcomes and Practice Patterns Study in 2014 to characterize the distribution of cinacalcet prescription across 203 United States hemodialysis

SUBMITTER: Fuller DS 

PROVIDER: S-EPMC6390908 | biostudies-literature | 2019 Feb

REPOSITORIES: biostudies-literature